Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American Electric Power Company Inc (AEP) vs ResMed Inc. (RMD) Price & Performance

American Electric Power Company IncTrade
ResMed Inc.Trade

Price performance (Past 24H)

Key statistics

American Electric Power Company Inc vs ResMed Inc. — how do they compare? American Electric Power Company Inc trades at $123.7 (market cap $66.87B), while ResMed Inc. trades at $223.62 (market cap $31.92B). The key difference: American Electric Power Company Inc is far larger — about 2.1× ResMed Inc.'s market cap, and American Electric Power Company Inc pays the higher dividend (3.09%). Which is the better fit depends on your goals.

AEPRMD
Market Cap
$66.87B$31.92B
Sector
UtilitiesHealth
52-Week High
$138.69$293.73
52-Week Low
$106.44$182.82
Enterprise Value
$119.77B$31.28B
Dividend Yield
3.09%1.2%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American Electric Power Company Inc

American Electric Power (AEP) trades at $125.73, up 0.38% on the day, with a bearish technical signal but strong analyst support. Recent Q2 2026 earnings missed estimates at $1.36 per share versus $1.48 expected, though the company raised full-year 2026 operating EPS guidance to $6.25–$6.55, reflecting confidence in AI-driven power demand growth. Fundamentals show robust revenue growth to $21.88B in 2025 and a net income margin of 13.78%, supported by a $78 billion capital plan.

The outlook remains positive due to contracted load growth and infrastructure investments, but risks include execution of large capital expenditures and interest rate sensitivity. With a consensus price target of $140.89 and no sell ratings, Wall Street sentiment is bullish, though technical indicators suggest near-term caution amid bearish moving averages.

ResMed Inc.

ResMed (RMD) trades at $211.94, down 5.06% on the day, following a Q4 2026 earnings beat but weaker fiscal 2027 revenue guidance. The stock shows strong fundamentals with a 26.94% net income margin and consistent earnings beats, while technical indicators are neutral with support at $204 and resistance at $218. Recent news highlights growth in sleep device demand but concerns over sales forecasts.

Outlook remains mixed: robust profitability and a $235 consensus price target suggest upside, but near-term pressure from guidance and technical neutrality poses risks. Investors should weigh solid financial health against market sentiment shifts.

Returns comparison

Trailing returns across standard periods

About American Electric Power Company Inc

American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 43% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (19%), nuclear (7%), and demand response (4%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.

Read more on AEP

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD